The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Uterine Cervicitis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Uterine Cervicitis


High impact information on Uterine Cervicitis


Chemical compound and disease context of Uterine Cervicitis


Biological context of Uterine Cervicitis


Anatomical context of Uterine Cervicitis


Gene context of Uterine Cervicitis

  • In the present study, we compared the secretion of MMP-2, MMP-3 and MMP-9 among 29 benign and premalignant cervical lesions (cervicitis and cervical intraepithelial neoplasias) and 46 tumoral explants of Ce Ca [18].
  • Signs, symptoms and sequelae of chlamydial infection (mucopurulent cervicitis, vaginal or urethral discharge; dysuria; lower abdominal pain; abnormal vaginal bleeding; and pelvic inflammatory disease) were analyzed for associations with serotype and ompA polymorphisms [19].
  • The lowered plasma T-SOD activity in the cervicitis patients was attributed to decreased Mn-SOD activity whereas the lowered plasma T-SOD activity in myoma patients was attributed to decreased activities of both Cu,Zn-SOD and Mn-SOD [20].
  • No immunoreactivity was detected in chronic cervicitis, while nuclear p53 reactivity was detected in all carcinoma and in squamous intra-epithelial lesions (SIL) overlying 8 sqcc [21].
  • Forty-seven cases of women with cervicitis or CIN were examined for the presence of K-ras mutations and HPV infection using PCR-RFLP methodology [14].

Analytical, diagnostic and therapeutic context of Uterine Cervicitis


  1. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. Stamm, W.E., Guinan, M.E., Johnson, C., Starcher, T., Holmes, K.K., McCormack, W.M. N. Engl. J. Med. (1984) [Pubmed]
  2. Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. Batteiger, B.E., Jones, R.B., White, A. Am. J. Med. (1989) [Pubmed]
  3. Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions. Buyukbayram, H., Arslan, A. Int. J. Cancer (2002) [Pubmed]
  4. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. Anzala, A.O., Simonsen, J.N., Kimani, J., Ball, T.B., Nagelkerke, N.J., Rutherford, J., Ngugi, E.N., Bwayo, J.J., Plummer, F.A. J. Infect. Dis. (2000) [Pubmed]
  5. Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. Kaul, R., Rowland-Jones, S.L., Gillespie, G., Kimani, J., Dong, T., Kiama, P., Simonsen, J.N., Bwayo, J.J., McMichael, A.J., Plummer, F.A. J. Infect. Dis. (2002) [Pubmed]
  6. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. Martin, D.H., Mroczkowski, T.F., Dalu, Z.A., McCarty, J., Jones, R.B., Hopkins, S.J., Johnson, R.B. N. Engl. J. Med. (1992) [Pubmed]
  7. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Romanowski, B., Talbot, H., Stadnyk, M., Kowalchuk, P., Bowie, W.R. Ann. Intern. Med. (1993) [Pubmed]
  8. Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group. Jones, R.B., Schwebke, J., Thorpe, E.M., Dalu, Z.A., Leone, P., Johnson, R.B. Am. J. Med. (1998) [Pubmed]
  9. Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis/cervicitis. Mogabgab, W.J. Am. J. Med. (1991) [Pubmed]
  10. Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis. Segreti, J. Am. J. Med. (1991) [Pubmed]
  11. Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis. Robson, H.G., Shah, P.P., Lalonde, R.G., Hayes, L., Senikas, V.M. Sexually transmitted diseases. (1983) [Pubmed]
  12. Interrelationships of bacterial vaginosis and cervical inflammation. Schwebke, J.R., Weiss, H.L. Sexually transmitted diseases. (2002) [Pubmed]
  13. Prediction of pelvic inflammatory disease among young, single, sexually active women. Ness, R.B., Smith, K.J., Chang, C.C., Schisterman, E.F., Bass, D.C. Sexually transmitted diseases. (2006) [Pubmed]
  14. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix. Prokopakis, P., Sourvinos, G., Koumantaki, Y., Koumantakis, E., Spandidos, D.A. Oncol. Rep. (2002) [Pubmed]
  15. Lipid peroxidation and antioxidant status in cervical cancer patients. Manoharan, S., Kolanjiappan, K., Kayalvizhi, M., Sethupathy, S. J. Biochem. Mol. Biol. Biophys. (2002) [Pubmed]
  16. Complications of pregnancy and labor in former oral contraceptive users. Harlap, S., Davies, A.M., Baras, M. Contraception. (1981) [Pubmed]
  17. Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis. Worm, A.M., Osterlind, A. Genitourinary medicine. (1995) [Pubmed]
  18. Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix. Argüello-Ramírez, J., Pérez-Cárdenas, E., Delgado-Chávez, R., Solorza-Luna, G., Villa-Treviño, S., Arenas-Huertero, F. Int. J. Gynecol. Cancer (2004) [Pubmed]
  19. Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Millman, K., Black, C.M., Stamm, W.E., Jones, R.B., Hook, E.W., Martin, D.H., Bolan, G., Tavaré, S., Dean, D. Microbes Infect. (2006) [Pubmed]
  20. Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma. Chiou, J.F., Hu, M.L. Clin. Biochem. (1999) [Pubmed]
  21. p53 immunohistochemical expression of Egyptian cervical carcinoma. Abd El All, H., Rye, A., Duvillard, P. Pathol. Oncol. Res. (1999) [Pubmed]
  22. p53 status and human papillomavirus infection in Thai women with cervical carcinoma. Limpaiboon, T., Pooart, J., Bhattarakosol, P., Niruthisard, S., Chantratita, W., Lulitanond, V. Southeast Asian J. Trop. Med. Public Health (2000) [Pubmed]
WikiGenes - Universities